[ad_1] An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s…
Tag: Keytruda
Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth
[ad_1] Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped…
Transgene and BioInvent – First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab) | BioSpace
[ad_1] STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)– Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq…
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
[ad_1] Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a quarterly loss,…
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreading
[ad_1] Asbe | Istock | Getty Images Moderna‘s experimental cancer vaccine, used in combination with Merck‘s Keytruda, reduced the risk of the most deadly form of skin cancer spreading to…
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
[ad_1] FLORHAM PARK, N.J., March 30, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious…